Prestige Consumer Healthcare (PBH) Revenue & Revenue Breakdown
Prestige Consumer Healthcare Revenue Highlights
Latest Revenue (Y)
$1.13B
Latest Revenue (Q)
$267.14M
Main Segment (Y)
Women's Health
Main Geography (Y)
North American OTC Healthcare
Prestige Consumer Healthcare Revenue by Period
Prestige Consumer Healthcare Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-03-31 | $1.13B | -0.21% |
| 2023-03-31 | $1.13B | 3.76% |
| 2022-03-31 | $1.09B | 15.21% |
| 2021-03-31 | $943.37M | -2.04% |
| 2020-03-31 | $963.01M | -1.31% |
| 2019-03-31 | $975.78M | -6.28% |
| 2018-03-31 | $1.04B | 18.04% |
| 2017-03-31 | $882.06M | 9.40% |
| 2016-03-31 | $806.25M | 12.82% |
| 2015-03-31 | $714.62M | 18.73% |
| 2014-03-31 | $601.88M | -3.48% |
| 2013-03-31 | $623.60M | 41.38% |
| 2012-03-31 | $441.08M | 31.08% |
| 2011-03-31 | $336.51M | 11.42% |
| 2010-03-31 | $302.02M | -3.42% |
| 2009-03-31 | $312.71M | -4.25% |
| 2008-03-31 | $326.60M | 2.50% |
| 2007-03-31 | $318.63M | 7.40% |
| 2006-03-31 | $296.67M | -2.19% |
| 2005-03-31 | $303.32M | 244.99% |
| 2004-03-31 | $87.92M | 22.56% |
| 2003-03-31 | $71.73M | 55.09% |
| 2002-03-31 | $46.25M | 434.41% |
| 2001-03-31 | $8.65M | - |
Prestige Consumer Healthcare generated $1.13B in revenue during NA 2024, up -0.21% compared to the previous quarter, and up 115.33% compared to the same period a year ago.
Prestige Consumer Healthcare Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | $267.14M | -3.56% |
| 2024-03-31 | $276.99M | -2.03% |
| 2023-12-31 | $282.74M | -1.25% |
| 2023-09-30 | $286.32M | 2.51% |
| 2023-06-30 | $279.31M | -2.29% |
| 2023-03-31 | $285.87M | 3.75% |
| 2022-12-31 | $275.52M | -4.75% |
| 2022-09-30 | $289.27M | 4.41% |
| 2022-06-30 | $277.06M | 3.79% |
| 2022-03-31 | $266.94M | -2.74% |
| 2021-12-31 | $274.47M | -0.64% |
| 2021-09-30 | $276.23M | 2.62% |
| 2021-06-30 | $269.18M | 13.21% |
| 2021-03-31 | $237.76M | -0.43% |
| 2020-12-31 | $238.79M | 0.58% |
| 2020-09-30 | $237.42M | 3.50% |
| 2020-06-30 | $229.39M | -8.69% |
| 2020-03-31 | $251.24M | 4.01% |
| 2019-12-31 | $241.55M | 1.46% |
| 2019-09-30 | $238.07M | 2.55% |
| 2019-06-30 | $232.15M | -3.68% |
| 2019-03-31 | $241.03M | -0.16% |
| 2018-12-31 | $241.41M | 0.86% |
| 2018-09-30 | $239.36M | -5.76% |
| 2018-06-30 | $253.98M | -0.78% |
| 2018-03-31 | $255.97M | -5.41% |
| 2017-12-31 | $270.62M | 4.88% |
| 2017-09-30 | $258.03M | 0.57% |
| 2017-06-30 | $256.57M | 6.61% |
| 2017-03-31 | $240.67M | 11.03% |
| 2016-12-31 | $216.76M | 0.80% |
| 2016-09-30 | $215.05M | 2.61% |
| 2016-06-30 | $209.57M | 0.83% |
| 2016-03-31 | $207.85M | 3.83% |
| 2015-12-31 | $200.19M | -2.85% |
| 2015-09-30 | $206.06M | 7.25% |
| 2015-06-30 | $192.13M | 1.10% |
| 2015-03-31 | $190.05M | -3.83% |
| 2014-12-31 | $197.61M | 9.01% |
| 2014-09-30 | $181.27M | 24.41% |
| 2014-06-30 | $145.70M | 1.00% |
| 2014-03-31 | $144.26M | -1.34% |
| 2013-12-31 | $146.21M | -13.20% |
| 2013-09-30 | $168.44M | 17.82% |
| 2013-06-30 | $142.97M | -7.47% |
| 2013-03-31 | $154.51M | -3.57% |
| 2012-12-31 | $160.23M | -1.00% |
| 2012-09-30 | $161.85M | 10.11% |
| 2012-06-30 | $147.00M | 9.70% |
| 2012-03-31 | $134.00M | 26.11% |
| 2011-12-31 | $106.25M | 0.67% |
| 2011-09-30 | $105.54M | 10.76% |
| 2011-06-30 | $95.30M | -1.11% |
| 2011-03-31 | $96.36M | 6.35% |
| 2010-12-31 | $90.61M | 15.71% |
| 2010-09-30 | $78.30M | 6.64% |
| 2010-06-30 | $73.42M | 2.86% |
| 2010-03-31 | $71.38M | -5.39% |
| 2009-12-31 | $75.45M | -10.37% |
| 2009-09-30 | $84.18M | 14.96% |
| 2009-06-30 | $73.22M | 3.35% |
| 2009-03-31 | $70.85M | -11.74% |
| 2008-12-31 | $80.28M | -8.83% |
| 2008-09-30 | $88.05M | 19.74% |
| 2008-06-30 | $73.53M | -8.58% |
| 2008-03-31 | $80.43M | - |
Prestige Consumer Healthcare generated $267.14M in revenue during Q1 2025, up -3.56% compared to the previous quarter, and up 93.45% compared to the same period a year ago.
Prestige Consumer Healthcare Revenue Breakdown
Prestige Consumer Healthcare Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Mar 24 | Mar 23 | Mar 22 | Mar 21 | Mar 20 |
|---|---|---|---|---|---|
| Analgesics | $117.45M | - | - | - | - |
| Cough and Cold | $119.02M | - | - | - | - |
| Dermatologicals | $129.10M | - | - | - | - |
| Eye and Ear Care | $179.42M | - | - | - | - |
| Gastrointestinal | $231.61M | - | - | - | - |
| Oral Care | $96.31M | - | - | - | - |
| Other OTC | $12.03M | - | - | - | - |
| Women's Health | $240.42M | - | - | - | - |
| Product and Service, Other | - | $107.00K | $42.00K | $41.00K | $74.00K |
| Product | - | $1.13B | $1.09B | $943.32M | $962.94M |
Prestige Consumer Healthcare's latest annual revenue breakdown by segment (product or service), as of Mar 24: Women's Health (21.36%), Gastrointestinal (20.58%), Eye and Ear Care (15.94%), Dermatologicals (11.47%), Cough and Cold (10.58%), Analgesics (10.44%), Oral Care (8.56%), and Other OTC (1.07%).
Quarterly Revenue by Product
| Product/Service | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Oral Care | $50.06M | $23.46M | $22.78M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Eye and Ear Care | $87.48M | $45.07M | $46.87M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Dermatologicals | $66.85M | $27.77M | $34.49M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Cough and Cold | $52.61M | $33.17M | $33.23M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Analgesics | $55.82M | $30.27M | $31.36M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Women's Health | $120.08M | $58.27M | $62.07M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other OTC | $6.17M | $3.11M | $2.75M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gastrointestinal | $117.22M | $61.63M | $52.76M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Product and Service, Other | - | - | - | $10.00K | $34.00K | $29.00K | $9.00K | $35.00K | $9.00K | $16.00K | $8.00K | $9.00K | $9.00K | $9.00K | $13.00K | $10.00K | $28.00K | $7.00K | $18.00K | $21.00K |
| Product | - | - | - | $279.30M | $285.83M | $275.50M | $289.26M | $277.02M | $266.93M | $274.45M | $276.22M | $269.17M | $237.75M | $238.78M | $237.41M | $229.38M | $251.21M | $241.54M | $238.05M | $232.13M |
Prestige Consumer Healthcare's latest quarterly revenue breakdown by segment (product or service), as of Mar 24: Women's Health (21.59%), Gastrointestinal (21.07%), Eye and Ear Care (15.73%), Dermatologicals (12.02%), Analgesics (10.03%), Cough and Cold (9.46%), Oral Care (9.00%), and Other OTC (1.11%).
Prestige Consumer Healthcare Revenue Breakdown by Country
Annual Revenue by Country
| Country | Mar 24 | Mar 23 | Mar 22 | Mar 21 | Mar 20 |
|---|---|---|---|---|---|
| North American OTC Healthcare | $958.26M | - | - | - | - |
| UNITED STATES | - | $953.22M | $910.11M | $799.04M | $812.65M |
| Non-US | - | $174.50M | $176.71M | $144.33M | $150.36M |
Prestige Consumer Healthcare's latest annual revenue breakdown by geography, as of Mar 24: North American OTC Healthcare (100.00%).
Quarterly Revenue by Country
| Country | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| North American OTC Healthcare | $422.32M | $236.56M | $244.42M | $54.95M | $242.32M | $53.92M | $59.38M | $61.18M | - | - | - | - | - | - | - | - | - | - | - | - |
| UNITED STATES | - | - | - | - | - | - | - | - | $219.57M | $227.72M | $236.15M | $226.67M | $199.11M | $197.30M | $203.29M | $199.35M | $208.39M | $203.92M | $199.71M | $200.63M |
| Non-US | - | - | - | - | - | - | - | - | $47.36M | $46.76M | $40.07M | $42.51M | $38.65M | $41.49M | $34.13M | $30.05M | $42.84M | $37.63M | $38.35M | $31.52M |
Prestige Consumer Healthcare's latest quarterly revenue breakdown by geography, as of Mar 24: North American OTC Healthcare (100.00%).
Prestige Consumer Healthcare Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| PBH | Prestige Consumer Healthcare | $1.13B | $267.14M |
| PAHC | Phibro Animal Health | $977.89M | $263.22M |
| EVO | Evotec SE | $781.43M | $208.73M |
| PCRX | Pacira BioSciences | $674.98M | $178.02M |
| SUPN | Supernus Pharmaceuticals | $607.52M | $168.32M |
| AMPH | Amphastar Pharmaceuticals | $593.24M | $182.39M |
| COLL | Collegium Pharmaceutical | $566.77M | $144.92M |
| ANIP | ANI Pharmaceuticals | $486.82M | $138.04M |
| EGRX | Eagle Pharmaceuticals | $316.61M | $64.65M |
| DCPH | Deciphera Pharmaceuticals | $163.36M | $45.00M |
| SSIC | Silver Spike Investment | $11.72M | $2.76B |
| RGC | Regencell Bioscience | - | - |
PBH Revenue FAQ
What is Prestige Consumer Healthcare’s yearly revenue?
Prestige Consumer Healthcare's yearly revenue for 2024 was $1.13B, representing a decrease of -0.21% compared to 2023. The company's yearly revenue for 2023 was $1.13B, representing an increase of 3.76% compared to 2022. PBH's yearly revenue for 2022 was $1.09B, representing an increase of 15.21% compared to 2021.
What is Prestige Consumer Healthcare’s quarterly revenue?
Prestige Consumer Healthcare's quarterly revenue for Q1 2025 was $267.14M, a -3.56% decrease from the previous quarter (Q4 2024), and a -4.36% decrease year-over-year (Q1 2024). The company's quarterly revenue for Q4 2024 was $276.99M, a -2.03% decrease from the previous quarter (Q3 2024), and a -3.11% decrease year-over-year (Q4 2023). PBH's quarterly revenue for Q3 2024 was $282.74M, a -1.25% decrease from the previous quarter (Q2 2024), and a 2.62% increase year-over-year (Q3 2023).
What is Prestige Consumer Healthcare’s revenue growth rate?
Prestige Consumer Healthcare's revenue growth rate for the last 3 years (2022-2024) was 3.55%, and for the last 5 years (2020-2024) was 16.86%.
What are Prestige Consumer Healthcare’s revenue streams?
Prestige Consumer Healthcare's revenue streams in r 24 are Analgesics, Cough and Cold, Dermatologicals, Eye and Ear Care, Gastrointestinal, Oral Care, Other OTC, and Women's Health. Analgesics generated $117.45M in revenue, accounting 10.44% of the company's total revenue Cough and Cold generated $119.02M in revenue, accounting 10.58% of the company's total revenue Dermatologicals generated $129.1M in revenue, accounting 11.47% of the company's total revenue Eye and Ear Care generated $179.42M in revenue, accounting 15.94% of the company's total revenue Gastrointestinal generated $231.61M in revenue, accounting 20.58% of the company's total revenue Oral Care generated $96.3M in revenue, accounting 8.56% of the company's total revenue Other OTC generated $12.02M in revenue, accounting 1.07% of the company's total revenue Women's Health generated $240.42M in revenue, accounting 21.36% of the company's total revenue
What is Prestige Consumer Healthcare’s main source of revenue?
For the fiscal year ending Mar 24, the largest source of revenue of Prestige Consumer Healthcare was Women's Health. This segment made a revenue of $240.42M, representing 21.36% of the company's total revenue.